tiprankstipranks
Trending News
More News >
UroGen Pharma down over 50% after resuming trading
PremiumThe FlyUroGen Pharma down over 50% after resuming trading
17d ago
UroGen says FDA panel votes against benefit/risk of UGN-102
Premium
The Fly
UroGen says FDA panel votes against benefit/risk of UGN-102
17d ago
UroGen Pharma announces outcome of ODAC meeting for UGN-102
Premium
The Fly
UroGen Pharma announces outcome of ODAC meeting for UGN-102
17d ago
Positive Buy Rating for UroGen Pharma Driven by Promising UGN-102 Prospects and Strong Financial Position
PremiumRatingsPositive Buy Rating for UroGen Pharma Driven by Promising UGN-102 Prospects and Strong Financial Position
25d ago
UroGen Pharma Reports Q1 2025 Earnings and Pipeline Progress
Premium
Company Announcements
UroGen Pharma Reports Q1 2025 Earnings and Pipeline Progress
26d ago
UroGen Pharma’s Earnings Call: Progress and Challenges
Premium
Company Announcements
UroGen Pharma’s Earnings Call: Progress and Challenges
26d ago
Urogen Pharma’s UGN-102: Promising Efficacy and Market Potential Justify Buy Rating
PremiumRatingsUrogen Pharma’s UGN-102: Promising Efficacy and Market Potential Justify Buy Rating
1M ago
UroGen Pharma announces patient-reported outcomes on UGN-102
Premium
The Fly
UroGen Pharma announces patient-reported outcomes on UGN-102
1M ago
UroGen Pharma announces long-term follow up data from OPTIMA II Phase 2b study
Premium
The Fly
UroGen Pharma announces long-term follow up data from OPTIMA II Phase 2b study
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100